Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2007
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/14/2007CN100348196C Benzotriazepines as gastrin and cholecystokinin receptor ligands
11/13/2007US7294641 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss, composition comprising it and its uses
11/13/2007US7294640 kINESIN SPINDLE PROTEIN INHIBITOR; ANTIPROLIFERATIVE AGENTS; ANTICANCER AGENTS; 4-(2,5-DIFLUORPHENYL)-N-3-FLUOROPYRROLIDIN-3-YL)-2-HYDROXYMETHYL-2-PHENYL-2,5 -DIHYDROXY-1N-PYRROL-1-CARBOXAMIDE
11/13/2007US7294639 E.g., 3-(3'-{[(1-biphenyl-4-ylmethanoyl)methyl-amino]methyl}biphenyl-4-yl)-2-ethoxypropionic acid and 2-ethoxy-3-(3'-{[methyl-(6-oxo-6-phenylhexanoyl)amino]methyl}biphenyl-4-yl)propionic acid; regulating and/or restoring skin lipid metabolism; treating a wide variety of skin disorders
11/13/2007US7294636 Chemical compounds
11/13/2007US7294628 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
11/13/2007US7294624 Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
11/13/2007US7294622 Lactams and uses thereof
11/13/2007CA2342804C Vending machine
11/13/2007CA2292965C Pyrrolidine derivative hair growth compositions and uses
11/13/2007CA2248304C Surface modified carbonate materials
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/08/2007WO2007127635A2 Diketo-piperazine and piperidine derivatives as antiviral agents
11/08/2007WO2007126043A1 Use as drugs of carboxylic acid derivatives having thiazole rings
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007125374A2 Novel process for production of 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one (ziprasidone)
11/08/2007WO2007125110A1 N- ( 2-thiazolyl) -amide derivatives as gsk-3 inhibitors
11/08/2007WO2007125109A1 N- (2-thiazolyl) -amide derivatives as gsk-3 inhibitors
11/08/2007WO2007125103A2 Benzamide glucokinase activators
11/08/2007WO2007125061A1 Spirocompounds useful as modulators for dopamine d3 receptors
11/08/2007WO2007124546A1 Integrase inhibitors 3
11/08/2007WO2007124544A1 Integrase inhibitors - 1
11/08/2007WO2007107470A3 Pyrazoles as 11-beta-hsd-1
11/08/2007WO2007103550A3 Substituted aminothiazole derivatives with anti-hcv activity
11/08/2007WO2007095602A3 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
11/08/2007WO2007089557A3 Polycyclic 1, 2, 3, 4 -tetrahydro- isoquinoline derivatives and compositions comprising them as ppar modulators
11/08/2007WO2007084435A3 Methods for treating hepatitis c
11/08/2007US20070260058 N-phenyl-1,3-thiazol-2-amine derivatives, useful in the treatment of neurodegenerative disorders, such as Alzheimer's disease
11/08/2007US20070259942 Indolone derivatives like N2-[2-(5-Methyl-1H-3-indolyl)ethyl]-N4-(4-methylphenyl)-6-(1-piperidinyl)-2,4-pyrimidinediamine; galanin-type receptors; antidepressants; anxiolytic agents
11/08/2007US20070259925 Dpp iv inhibitors
11/08/2007US20070259922 Aryl, aryloxy, alkyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/08/2007US20070259919 2-Substituted Pyridines, Processes for their Preparation and Their Use for Controlling Harmful Fungi
11/08/2007US20070259892 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
11/08/2007US20070259887 Inhibitors of polyq-aggregation
11/08/2007US20070259882 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
11/08/2007US20070259880 dipeptidyl peptidase IV (DPP-IV) inhibitors, useful for the prophylaxis or treatment of non-insulin dependent diabetes and obesity
11/08/2007US20070259874 Phosphodiesterase Inhibitors
11/08/2007US20070259862 3-{3-[(R)-1-(4-Methyl-5-pyrimidin-5-yl-4H-[1,2,4]triazol-3-yl)-pyrrolidin-2-yl]-isoxazol-5-yl}-benzonitrile; metabotropic glutamate receptors (mGluRs); have a limited ability of passing the blood-brain barrier
11/08/2007US20070259855 Thiazolyl-dihydro-indazole
11/08/2007US20070259852 Such as 2-(2-hydroxycarbamoylmethyl-3-oxo-2,3-dihydro-benzo[1,4]thiazin-4-yl)-propionamide; peptidyl deformylase (PDF) inhibitors; for treatment of bacterial infections
11/08/2007US20070259848 N-({[1-(3,4-Dichloro-benzyl)-azetidin-3-ylmethyl]-carbamoyl}-methyl)-2-methoxy-benzamide; inflammatory or allergic condition such as an inflammatory or obstructive airways disease
11/08/2007US20070259847 1-(1,5-dimethyl-1H-pyrazole-3-carbonyl)piperidine-3-carboxylic acid [4-(5-cyclohexyl-2-methoxyphenyl)thiazol-2-yl]amide; chemokine receptor modulators
11/08/2007DE102006012251A1 Substituierte 4-Amino-chinazolin-Derivate und ihre Verwendung zur Herstellung von Arzneimitteln Substituted 4-amino-quinazoline derivatives and to their use for the preparation of medicaments
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007CA2650382A1 Diketo-piperazine and piperidine derivatives as antiviral agents
11/08/2007CA2650326A1 N-(2-thiazolyl)-amide derivatives as gsk-3 inhibitors
11/08/2007CA2650323A1 N-(2-thiazolyl)-amide derivatives as gsk-3 inhibitors
11/08/2007CA2649577A1 Benzamide glucokinase activators
11/08/2007CA2649374A1 Novel process for production of 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one (ziprasidone)
11/08/2007CA2647338A1 Integrase inhibitors-3
11/07/2007EP1852433A1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
11/07/2007EP1852428A1 4-cyclopropyl-1,2,3-thiadiazole compound, agrohorticultural plant disease controlling agent and method of using the same
11/07/2007EP1851215A1 Water-soluble tetrazolium salts
11/07/2007EP1851204A1 Naphthalene derivatives as modulators of the glucocorticoid receptor
11/07/2007EP1851202A1 Pyridyl acetic acid compounds
11/07/2007EP1850846A1 Composition comprising a jnk inhibitor and cyclosporin
11/07/2007EP1623977B1 Intermediate compound which is used for the preparation of pioglitazone
11/07/2007EP1192151B1 Anilinoquinazolines as protein tyrosine kinase inhibitors
11/07/2007EP1087941B9 Thiolesters and uses thereof
11/07/2007CN101068810A Carbostyril compound
11/07/2007CN101068803A Biaryloxymethylarene carboxylic acid compounds
11/07/2007CN101068780A Methods for the preparation of stereoisomerically enriched amines
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101068770A Method for producing 6-substituted-1-methyl-1-H-benzimidazole derivative and its production intermediate
11/07/2007CN101066972A [1,2,3]-thiobizole derivative and its synthesis process and use
11/07/2007CN100347161C Pna单体和前体 Pna monomers and precursors
11/07/2007CN100346792C Benzothiazole derivatives as adenosine receptor ligands
11/06/2007US7291740 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Mesylate salt
11/06/2007US7291641 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
11/06/2007US7291636 E.g., Methyl 2-[2-[2-(3,5-difluorophenyl)acetyl-amino]propanoylamino]-5-propylthiazole-4-carboxylate; beta -amyloid peptide inhibitors; used to treat senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy and/or cerebrovascular disorders
11/06/2007US7291635 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents
11/06/2007US7291631 aminoalkylpyridines, e.g., N-(1H-benzimidazol-2-ylmethyl)-N-(3-methylpyridin-2-ylmethyl)-butane-1,4-diamine; treating HIV infection and inflammatory conditions such as rheumatoid arthritis; elevating progenitor and stem cell counts, as well as white blood cell counts
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/06/2007US7291619 Melanocortin receptor agonists
11/06/2007US7291618 (3,3-Difluoropyrrolidin-1-yl)-((2S,4S)-4-(4-(pyrimidin-2-yl) piperazin-1-yl)pyrrolidin-2-yl)methanone, usedin treating diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, and the like.
11/06/2007US7291613 Inhibitors of p38 kinase
11/06/2007US7291611 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain
11/06/2007CA2241666C Tricyclic compounds, their production and use
11/01/2007WO2007124337A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/01/2007WO2007124316A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007WO2007123936A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
11/01/2007WO2007123269A1 Azolecarboxamide derivative
11/01/2007WO2007122482A1 Fused phenyl amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases
11/01/2007WO2007122241A1 Compounds which potentiate ampa receptor and uses thereof in medicine
11/01/2007WO2007122173A1 Substituted pyrazinone derivatives for use as a medicine
11/01/2007WO2007106879A3 Process for preparing n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide and related metabolites thereof
11/01/2007WO2007095124A3 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
11/01/2007WO2007075598A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
11/01/2007WO2007068815A3 Heterocyclic derivatives, preparation and therapeutic use thereof
11/01/2007WO2007061923A3 Glucokinase activators
11/01/2007WO2007047146A3 Inhibitors of viral replication
11/01/2007WO2006097460A8 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
11/01/2007WO2002090332A3 Novel aeylheteroalkylaminε derivatives
11/01/2007US20070255063 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
11/01/2007US20070255055 Epothilone derivatives
11/01/2007US20070254935 Pyrazole and imidazole compounds and uses thereof
11/01/2007US20070254925 Thiazole and thiadiazole compounds for inflammation and immune-related uses
11/01/2007US20070254867 Heterocyclic Kinase Inhibitors
11/01/2007CA2649736A1 Heterocyclic compounds as inhibitors of c-fms kinase
1 ... 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 ... 628